PGR and breast cancer: Moreover, these effects were not unique to ErbB2-positive BC since erastin had a similar impact on MDA-MB-468 and HCC-1806 cells (Fig. 2F, G) derived from the triple-negative BCs lacking ErbB2, estrogen and progesterone receptors [29].